Nektar Therapeutics
NKTR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000906709
In the last 90 days, Nektar Therapeutics insiders filed 0 open-market purchases and 2 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Nektar Therapeutics changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 140 | 146 | +6 |
| Shares | 140.8M | 132.9M | −7.87M (−5.6%) |
| Value | $182.9M | $123.6M | −$59.4M (−32.5%) |
New holders (22)
Institutions that held Nektar Therapeutics at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| 22NW, LP | 2,191,750 | $2.04M | 1.29% |
| Peapod Lane Capital LLC | 1,107,516 | $1.03M | 1.02% |
| Diadema Partners LP | 698,919 | $650.0K | 0.73% |
| Exome Asset Management LLC | 618,174 | $574.9K | 0.43% |
| Prelude Capital Management, LLC | 183,413 | $170.6K | 0.01% |
| Persistent Asset Partners Ltd | 166,572 | $137.8K | 0.12% |
| Squarepoint Ops LLC | 139,758 | $130.0K | 0.00% |
| Susquehanna International Group, LLP | 83,301 | $77.5K | 0.00% |
| Qube Research & Technologies Ltd | 65,759 | $61.2K | 0.00% |
| Police & Firemen's Retirement System of New Jersey | 35,891 | $33.4K | 0.00% |
| US Asset Management LLC | 33,484 | $31.0K | 0.03% |
| Harvest Investment Services, LLC | 29,244 | $27.2K | 0.01% |
| CIBC World Markets Corp | 16,707 | $15.5K | 0.00% |
| R Squared Ltd | 3,720 | $3.46K | 0.00% |
| Whipplewood Advisors, LLC | 800 | $744 | 0.00% |
| Atlas Capital Advisors LLC | 600 | $558 | 0.00% |
| Jones Financial Companies LLLP | 400 | $372 | 0.00% |
| Ameriflex Group, Inc. | 200 | $165 | 0.00% |
| EverSource Wealth Advisors, LLC | 171 | $159 | 0.00% |
| Medallion Wealth Advisors, LLC | 207 | $141 | 0.00% |
| SBI Securities Co., Ltd. | 14 | $13 | 0.00% |
| Cornerstone Planning Group LLC | 5 | $4 | 0.00% |
Sold out (16)
Institutions that held Nektar Therapeutics at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Acuitas Investments, LLC | 1,096,445 | $1.43M |
| Balyasny Asset Management LLC | 300,352 | $390.5K |
| ExodusPoint Capital Management, LP | 280,366 | $364.0K |
| Gsa Capital Partners LLP | 214,245 | $279.0K |
| Jane Street Group, LLC | 91,470 | $118.9K |
| Candriam Luxembourg S.C.A. | 79,594 | $103.5K |
| Values First Advisors, Inc. | 44,762 | $58.2K |
| Erste Asset Management GmbH | 46,800 | $54.8K |
| Storebrand Asset Management AS | 30,875 | $40.1K |
| Group One Trading, L.P. | 27,138 | $35.3K |
| Valence8 US LP | 26,107 | $33.9K |
| Engineers Gate Manager LP | 13,398 | $17.4K |
| GWM Advisors LLC | 1,500 | $1.95K |
| Founders Capital Management | 700 | $910 |
| Smartleaf Asset Management LLC | 282 | $329 |
| Capital Performance Advisors LLP | 66 | $86 |